News

Needham initiated coverage of Philip Morris International (NYSE:PM) on Thursday with a Buy rating. Analyst Gerald Pascarelli ...
Zacks Investment Research on MSN12dOpinion
Bull of the Day: Philip Morris (PM)
Philip Morris Company OverviewZacks Rank #1 (Strong Buy) stock Philip Morris International (PM) is an international ...
Three years after raising health groups’ suspicions by acquiring Vectura, a British pharmaceutical firm that makes asthma inhalers, cigarette giant Philip Morris International has made a deal to ...
Below, we take a look at Philip Morris (PM), a company that currently holds a Momentum Style Score of B. We also talk about price change and earnings estimate revisions, two of the main aspects of ...
Altria and Philip Morris share a history and sell the same brands, but in different parts of the world. Philip Morris has entered the U.S. market, competing with Altria in non-cigarette businesses.
Philip Morris' strong 2024 results, highlighted by 10% organic revenue growth and 9% adjusted EPS growth, was driven by its reduced-risk products. Smoke-free revenue grew 17% organically and gross ...
Tobacco juggernaut Philip Morris International reported a strong quarter, including a 5.8% growth in revenue, in large part because of the soaring popularity of Zyn. U.S. shipments of the nicotine ...
STAMFORD, Conn. (AP) — STAMFORD, Conn. (AP) — Philip Morris International Inc. (PM) on Wednesday reported first-quarter profit of $2.69 billion. On a per-share basis, the Stamford, Connecticut ...
Philip Morris International said Tuesday it is planning to invest $600 million to open a manufacturing plant in Colorado to keep up with steep demand for Zyn nicotine pouches. The tobacco giant ...
Sept 17 (Reuters) - Philip Morris International's (PM.N), opens new tab Vectura Fertin Pharma said on Tuesday it would sell its asthma inhaler maker Vectura Group to Molex Asia Holdings for 150 ...